148 related articles for article (PubMed ID: 22011078)
21. [A case of postoperative liver metastasis of mucinous carcinoma of the breast with complete response to sequential administration of FEC75, tamoxifen citrate, and letrozole].
Shibaki T; Morimoto N
Gan To Kagaku Ryoho; 2010 Mar; 37(3):499-501. PubMed ID: 20332691
[TBL] [Abstract][Full Text] [Related]
22. Choroidal metastases as a presenting sign after 24 years of a primary breast cancer.
Gupta R; Consul S; Baheti D
Indian J Cancer; 1991 Sep; 28(3):168-70. PubMed ID: 1786984
[TBL] [Abstract][Full Text] [Related]
23. [Nineteen years postoperatively, anastrozole, UFT and cyclophosphamide combination therapy remained effective against recurrent hormone responsive breast cancer with intraabdominal lymphnode, pleural, skin and bone metastases in old age following sixteen-year tamoxifen treatment - a case report].
Sakurai T; Umemura T; Jinta E; Suzuma T; Yoshimura G; Shimizu S; Sakurai T
Gan To Kagaku Ryoho; 2009 May; 36(5):819-21. PubMed ID: 19461185
[TBL] [Abstract][Full Text] [Related]
24. Choroidal metastasis as a first sign of recurrence in a patient with gastric adenocarcinoma.
Sahin A; Kiratli H
Can J Ophthalmol; 2007 Apr; 42(2):331-2. PubMed ID: 17392868
[TBL] [Abstract][Full Text] [Related]
25. Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17.
Muss HB; Tu D; Ingle JN; Martino S; Robert NJ; Pater JL; Whelan TJ; Palmer MJ; Piccart MJ; Shepherd LE; Pritchard KI; He Z; Goss PE
J Clin Oncol; 2008 Apr; 26(12):1956-64. PubMed ID: 18332474
[TBL] [Abstract][Full Text] [Related]
26. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability.
Mouridsen H; Sun Y; Gershanovich M; Perez-Carrion R; Becquart D; Chaudri-Ross HA; Lang R
Oncologist; 2004; 9(5):489-96. PubMed ID: 15477633
[TBL] [Abstract][Full Text] [Related]
27. [A case report of advanced breast cancer effectively treated by chemo-endocrine therapy with diethylstilbestrol diphosphate and cyclophosphamide].
Hareyama M; Saito A; Oouchi A; Morita K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2453-6. PubMed ID: 2751322
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.
von Minckwitz G; Eidtmann H; Rezai M; Fasching PA; Tesch H; Eggemann H; Schrader I; Kittel K; Hanusch C; Kreienberg R; Solbach C; Gerber B; Jackisch C; Kunz G; Blohmer JU; Huober J; Hauschild M; Fehm T; Müller BM; Denkert C; Loibl S; Nekljudova V; Untch M; ;
N Engl J Med; 2012 Jan; 366(4):299-309. PubMed ID: 22276820
[TBL] [Abstract][Full Text] [Related]
29. [A case of stage IV breast cancer with long-term partial response treated with tri-weekly paclitaxel plus bevacizumab].
Okamoto A; Nakatsukasa K; Fujita Y; Sugimoto R; Sakaguchi K; Taguchi T
Gan To Kagaku Ryoho; 2015 Mar; 42(3):343-6. PubMed ID: 25812504
[TBL] [Abstract][Full Text] [Related]
30. Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.
Dowsett M; Ebbs SR; Dixon JM; Skene A; Griffith C; Boeddinghaus I; Salter J; Detre S; Hills M; Ashley S; Francis S; Walsh G; Smith IE
J Clin Oncol; 2005 Apr; 23(11):2477-92. PubMed ID: 15767642
[TBL] [Abstract][Full Text] [Related]
31. A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
Tanaka Y; Ohmori Y; Toki T; Okazaki Y; Ogoshi S; Ogawa Y
Nihon Geka Hokan; 1995 Jan; 64(1):15-22. PubMed ID: 8534185
[TBL] [Abstract][Full Text] [Related]
32. L-BLP25 vaccine plus letrozole induces a TH1 immune response and has additive antitumor activity in MUC1-expressing mammary tumors in mice.
Mehta NR; Wurz GT; Burich RA; Greenberg BE; Griffey S; Gutierrez A; Bell KE; McCall JL; Wolf M; DeGregorio M
Clin Cancer Res; 2012 May; 18(10):2861-71. PubMed ID: 22434666
[TBL] [Abstract][Full Text] [Related]
33. A case of prolonged disease-free survival in a patient with choroidal metastasis from breast cancer.
Jang RW; Doherty M; Hopkins JJ; Warner E
Nat Clin Pract Oncol; 2009 Feb; 6(2):118-21. PubMed ID: 19065141
[TBL] [Abstract][Full Text] [Related]
34. Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab.
Munzone E; Nolè F; Sanna G; Goldhirsch A
Breast; 2005 Oct; 14(5):380-3. PubMed ID: 16216740
[TBL] [Abstract][Full Text] [Related]
35. [Effect of combination chemotherapy of 5'-DFUR, cyclophosphamide and tamoxifen in a case of advanced breast cancer].
Enomoto T; Watanabe A
Gan To Kagaku Ryoho; 1989 Jan; 16(1):131-4. PubMed ID: 2536266
[TBL] [Abstract][Full Text] [Related]
36. Optic nerve breast metastasis mimicking meningioma.
Backhouse O; Simmons I; Frank A; Cassels-Brown A
Aust N Z J Ophthalmol; 1998 Aug; 26(3):247-9. PubMed ID: 9717758
[TBL] [Abstract][Full Text] [Related]
37. Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.
Rossi E; Morabito A; De Maio E; Di Rella F; Esposito G; Gravina A; Labonia V; Landi G; Nuzzo F; Pacilio C; Piccirillo MC; D'Aiuto G; D'Aiuto M; Rinaldo M; Botti G; Gallo C; Perrone F; de Matteis A
J Clin Oncol; 2008 Jan; 26(2):264-70. PubMed ID: 18086795
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
Goss PE; Ingle JN; Martino S; Robert NJ; Muss HB; Piccart MJ; Castiglione M; Tu D; Shepherd LE; Pritchard KI; Livingston RB; Davidson NE; Norton L; Perez EA; Abrams JS; Cameron DA; Palmer MJ; Pater JL;
J Clin Oncol; 2007 May; 25(15):2006-11. PubMed ID: 17452676
[TBL] [Abstract][Full Text] [Related]
39. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
[TBL] [Abstract][Full Text] [Related]
40. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
Wardley AM
Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
